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Abstract: Background and aim: Various laboratory tests with their own particular strengths and weaknesses exist 
for diagnosis of acute myocardial infarction (AMI). This study was conducted to determine the association of 
changes in electrocardiography, echocardiography and cardiac enzymes with One-month mortality in AMI patients 
referring to Hajar Hospital of Shahrekord in 2011. Materials and method: For this descriptive analytical study, 107 
AMI patients were randomly enrolled. For gathering data a questionnaire was used. Demographic data and test 
results of cardiac enzymes, EKG, and echocardiography according to the medical profile were registered in the 
questionnaire. The follow-up continued for 40 days through phone calls and medical profile and the mortality and/or 
any recurrent myocardial complication was entered into the medical profile. Data analysis was performed by SPSS 
11 using chi-square, Spearman correlation coefficient, and t test. Results: The mean age of patients was 
60.62 years. Mortality showed a direct association with age and personal history of ischemic heart disease 
(p<0.05). In addition, one-month mortality was directly associated with troponin, ejection fraction, and the number 
of segments involved in echocardiography (p<0.05); troponin level in outliving people was less, the mortality 
among patients with less ejection fraction was higher, and the number of involved segments was higher in the dead 
compared to the outliving. Conclusion: The findings of this study emphasize the value of echocardiography in 
determining the prognosis of AMI. Moreover, troponin could have a high prognostic value in addition to its high 
value in diagnosis. 
[Arsalan Khaledifar, Mahmoud Mobasheri. The association of changes in electrocardiography, 
echocardiography and cardiac enzymes with One-month mortality in AMI patients referring to Hajar 
Hospital of Shahrekord. Life Sci J 2013;11(9):432-436]. (ISSN: 1097-8135). http://www.lifesciencesite.com. 70 
 
Keywords: Electrocardiography, Echocardiography, Cardiac enzymes, Acute myocardial infarction 
 
1. Introduction 
Acute myocardial infarction (AMI), 
commonly known as heart attack, is actually the 
perfusion abnormality in some part of the heart, 
causing heart cells to die (1). This disease is the most 
common diagnosis in industrialized countries, so that 
650 thousand people annually in the United States are 
suffering from the new AMI and early mortality (in 30 
days) due to this disease is about 30% (2). The 
laboratory tests for the diagnosis of myocardial 
infarction are divided into four groups: 1. liver 
enzymes 2. Changes in the electrocardiography 3. 
Echocardiographic imaging, and 4. Nonspecific 
marker of inflammation and tissue necrosis (3). In 
2000, the highest value was for cardiac biomarkers in 
the WHO diagnostic criteria (4). These are proteins 
that are released from necrotic myocardium in a large 
amount into blood after infraction (5). Creatinine 
phosphokinase is one of these proteins or heart 
enzymes that enters blood, damaging myocardial cells, 
and begins to rise 4 to 8 hours after onset of stroke, 
then returns to normal after 2 to 3 days. This enzyme 
is at its peak for 24 hours. The larger the size of MI, 
the faster the enzyme will rise (6). But in 15% of cases 
of negative results, they are reported positive—false 
one (7). Another marker, Troponin, is not normally 
measurable in healthy subjects, but 3 hours after onset 
of chest, it begins to rise (8). The electrocardiography 
is also one of the first evaluations for patients, and if it 
is utilized during rib cage pain, it will diagnose 
correctly (9). Most patients with acute myocardial 
infarction undergo serial ECG changes, but some 
cases like extensive myocardial injury, infarct location, 
and presence of acute pericarditis and electrolyte 
changes limit the capability of ECG in MI diagnosis 
and localization (8). The two-dimensional 
echocardiography, wall motion (WM) abnormalities 
are always there, and although the echocardiography 
cannot differentiate acute myocardial infarction from 
old scars or ischemia, the simplicity and safety of this 
technique make it an interesting screening method; 
moreover, the assessment of left ventricular function 
by echocardiography may be important in determining 
the prognosis (2). In echocardiography, first the 
damaged myocardium is immobilized, but ventricular 
wall thickness is normal; after about 4 to 6 weeks, the 
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damaged area starts to thin, and increase echogenicity 
(10). Echocardiography may detect right ventricular 
infarction, ventricular aneurysm and pericardial 
effusion, too (5). Given that the acute myocardial 
infarction is one of the most common diagnoses in 
hospitalized patients, and is one of the most common 
causes of death in most communities, including our 
country, and includes life-threatening complications 
such as heart attack again, heart failure, ventricular 
septal defect, mitral valve failure as well as variety of 
arrhythmias—as mentioned above, various laboratory 
tests used for diagnosis of myocardial infarction, each 
with its own specific advantages and disadvantages; 
moreover, there is no study to investigate the 
performance of all tests simultaneously--this study, 
conducted in 1389, is an attempt to determine the 
association of changes in electrocardiography, 
echocardiography and cardiac enzyme with one-
month mortality in AMI patients going to Hajar 
hospital of Shahr-e-Kurd. 
 
2. Methodology 
In this analytic descriptive study, conducted 
in 2010, given that the sample size have the reliability 
of 90 percent, the precision of 7 percent and one-
month survival of 65%, we randomly selected 107 
acute myocardial infarction patients going to Hajar 
hospital of Shahr-e-Kurd (diagnosed according to 
WHO criteria, including enzymatic changes, clinical 
findings and ECG changes). Since the intended 
experiments were exactly the same tests routinely 
performed on these patients for diagnosing MI, there 
was no ethical prohibition. The data collection 
instrument was a questionnaire and demographic data, 
test results of cardiac enzymes, ECG on admission 
and re-tests based on patient files were recorded in the 
questionnaire. The echocardiography findings of 
patients regarding the number of involved segments, 
aortic valve, and the EF, were recorded in the 
questionnaire based on the patient files. The patients 
were followed up for 40 days with phone calls, and 
their meical records were reviewed. The results such 
as heart failure resulting in death, or readmission to 
the hospital was mentioned in the questionnaire. After 
40 days for all patients, the complete data was entered 
into SPSS v. 11.5. In order to compare the gender of 
subjects in the two groups, i.e. survived and died, as 
well as to compare the means of age, weight and the 
other quantitative variables between two groups, we 
used t-test. To determine the relationship between the 
personal and family history of ischemic heart disease 
and one-month mortality, the Spearman correlation 




3. Results  
This 107-subject population includes 82 male 
(76.6%), and 25 females (23.4%). The subjects had 
the age range of 32-85 years, and the mean of 
60.62years. More than half of the patients 
(n=58, 54.2%) had complications during 40-day 
follow-up period; 49 patients (45.8%) did not. 
seventeen patients out of total sample (15.9%) died in 
the first 30 days, so the one-month survival rate was 
84.1 percent. Death in the first month after a 
myocardial infarction was not associated with gender; 
the gender differences in the two groups was not 
significant (Table 1). The mean age of the patients 
who died were higher than that of those surviving; 
there was a significant relationship between age and 
one-month mortality (p<0.001). Among other 
demographic variables, the Spearman test showed a 
significant direct association between personal history 
of ischemic heart disease and one-month death 
(p=0.24, r=0.01). There is no significant relationship 
between family history of ischemic heart disease and 
one-month death (p=0.52, r=0.06). Other demographic 
variables (weight, the elapsed time period to go to the 
first medical center) were not significantly associated 
with mortality. In Table 2, the mean score of the 
studied variables in patients who survived is compared 
with that of patients who died. Laboratory, and 
diagnostic test results showed that the troponin 
enzyme, ejection fraction (EF) rate and the number of 
involved segment in echocardiography had a 
significant relationship with a one-month mortality (P 
<0.05), in a way that those who survived had lower 
troponin levels; moreover, lower EF rate in patients 
resulted in death. The number of involved segments in 
patients who died was higher than those of patients 
who survived. However, the mean of first creatinine 
phosphokinase, the highest creatinine phosphokinase, 
the highest STE in the electrocardiography, the sum of 
STE in the electrocardiography, and the number of 
involved leads in the two groups was not significantly 
different (Table 2). 
 
4. Discussion  
The present study was actually a descriptive 
analytical one. The subjects in this study were 107 
AMI patients who were randomly selected. The results 
indicate that among demographic variables, age and 
personal history of ischemic heart disease was directly 
related to mortality, and other demographic variables 
(gender, weight, the elapsed time period to go to the 
first medical center, and history myocardial infarction 
in near relatives) were not significantly associated 
with mortality. 
This study consisted of 76.6% male and 
23.4% female. In a study conducted by Amani et al., 
entitled “An assessment of survival rate in patients 
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with acute myocardial infarction”, the results were 
similar to those of the present study where a higher 
percentage of patients (72.8 percent) were male, and 
the rest (27.2 percent) female (11). 
According to the results shown in Table 1, in 
this study, the mortality rate within thirty days after 
acute myocardial infarction was 15.9%. The results of 
the study conducted by Cambou et al. in France on the 
one-year survival of AMI patients showed that the 
mortality rate in the first 28 days was 13.2 percent 
(12). In another study conducted by Ghafarian the 
mortality in AMI patients in the first month has been 
reported in 18% (13). Higher mortality rate in the first 
month was related to the lack of familiarity with the 
symptoms of the disease, self-medication, late check-
up, obesity and non-compliance with the physician 
orders (14). As the results showed, in older patients 
the risk of mortality had been significantly increased. 
In order to confirm the above results, a study 
conducted by Kubota showed mortality in AMI 
patients significantly increases with age (15). Another 
study done by Ghafarian showed that with increasing 
age, the mortality in patients rose up (13). 
The results of this study indicated that 
mortality rate was higher in patients with a personal 
history of ischemic heart disease. In this regard, a 
study was carried out in Ireland by McMahon, which 
represented that 60 percent of those whose premature 
death was caused by myocardial infarction had a 
history of heart failure, and 17 percent did not; 
therefore, this result indicated the relationship 
between the history of MI and premature death (16). 
In a study conducted by Hoseini (2003), it is observed 
that there is also a significant correlation between 
myocardial infarction and mortality within the first 28 
days after the attack (17). Similar results were also 
observed in the study by Nakanishi et al. where both 
short-term (one-month) and long term (one-year) 
survival in patients with a history of ischemic heart 
disease is low (18). 
According to the results in Table 2, there was 
not an association between the first and highest 
creatinine phosphokinase levels with one-month 
mortality. In a study conducted by Hoseini (2002), the 
results showed that changes in cardiac enzymes was 
not significant related to the mortality caused by heart 
attacks (17). 
In a study carried out by Fioretti et al., the 
results indicate that the highest creatinine 
phosphokinase levels associated with mortality within 
thirty days but not with mortality beyond thirty days 
(19). The amount of troponin in AMI patients was 
significantly associated with the one-month mortality, 
where troponin levels for patients who survived was 
lower. Therefore, it can be inferred that not only does 
troponin have high diagnostic value for acute 
myocardial infarction, but also has prognostic one. In 
a study on 260 patients conducted by Christianson et 
al. in the USA, such a result was achieved (20). Also, 
Ohman et al. represented the association between 
troponin levels and one-month mortality (21). There 
was no significant relationship between the patient's 
ECG data (the highest STE, total STE, the presence or 
absence of the Q wave) and the number of involved 
leads with mortality in patients, while in a study by 
Christianson et al. (2010), there was a significant 
relationship between total STE and survival of the 
patients (20). This difference in results may be due to 
differences in the number of sample sizes selected in 
the two studies, or differences in the research 
population, or in the instrument accuracy of ECG. 
The last part of the clinical cases was to 
investigate the relationship between 
echocardiographic data and the patient's death, where 
it was observed that the rate of EF and the number of 
involved segments in echocardiography has been 
associated with mortality, so that the lower the EF rate, 
the higher the mortality in patients. There was also 
observed that the number of involved segments in 
deceased people was more than that of those who 
survived. The abovementioned findings show the 
value of echocardiography in determining the 
prognosis of AMI patients. Investigating the 
relationship between complications of acute 
myocardial infarction with mortality, we observed that 
in patients with complications of acute myocardial 
infarction in the given term, the chance of survival 
was smaller than that of those with no complication.  
 
 
Table 1: Frequency and the comparison of gender in the two groups 
Significance of K 2 Sum (percent) Survived (percent) Died (percent) Variables 
P=0.16 25 (23.4) 19 (17.8) 6 (5.6) Female 
P=0.16 82 (76.6) 71 (66.3) 82 (76.6) Male 
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Age (year) 68.7±8.55 59.1±12.67 P=0.000 
Weight (KG) 65.47±10.05 67.86±65.47 P=0.31 
Time elapsed from appearing symptoms until taken to 
hospital 
17.52±26.56 901±13.64 P=0.21 
Troponin (microgram/liter) 10.81±5.98 6.97±5.40 P=0.01 
First creatinine phosphokinase 716.82±739.01 547.51±792.65 P=0.41 
Highest creatinine phosphokinase 2640.88±2709.25 2333.43±1616.91 P=0.55 
Highest STE in ECG 5.23±2.72 5.47±2.5 P=0.72 
Highest STE in ECG 15.61±7.22 14.88±6.88 P=0.70 
Number of involved lead in ECG 3.70±1.15 3.77±1.21 P=0.82 
Patients’ EF in echocardiography 28.23±10.14 39.97±10.36 P=0.000 
Number of involved segments in echocardiography 3.88±1.45 2.62±1.05 P=0.000 
 
5. Conclusion:  
The results of the present study represent the 
value of echocardiography in determining the 
prognosis of AMI patients. Moreover, it can be 
inferred that not only does troponin have high 
diagnostic value for acute myocardial infarction, but 
also has prognostic one. 
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